Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Rivastigmine and Huperzine A as Treatments for Cocaine Dependence

NCT01030692 is registered in ClinicalTrials.gov with Baylor College of Medicine as lead sponsor.

NCT NCT01030692
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01030692 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Rivastigmine and Huperzine A as Treatments for Cocaine Dependence
Lead sponsor
Baylor College of Medicine
Phase
Phase 1
Overall status
Completed
Start date
January 31, 2009
Completion date
June 30, 2014
Enrollment
72 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cocaine abuse, cocaine addiction, cocaine dependence, substance abuse